147 related articles for article (PubMed ID: 14563954)
1. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.
Okano H; Shiraki K; Inoue H; Yamanaka Y; Kawakita T; Saitou Y; Yamaguchi Y; Enokimura N; Yamamoto N; Sugimoto K; Murata K; Nakano T
Lab Invest; 2003 Oct; 83(10):1529-39. PubMed ID: 14563954
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.
Piva R; Gianferretti P; Ciucci A; Taulli R; Belardo G; Santoro MG
Blood; 2005 Feb; 105(4):1750-8. PubMed ID: 15498850
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma.
Okano H; Shiraki K; Inoue H; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Fujikawa K; Murata K; Nakano T
Anticancer Drugs; 2002 Jan; 13(1):59-65. PubMed ID: 11914642
[TBL] [Abstract][Full Text] [Related]
6. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
[TBL] [Abstract][Full Text] [Related]
7. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
[TBL] [Abstract][Full Text] [Related]
8. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
10. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
12. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
Ward C; Dransfield I; Murray J; Farrow SN; Haslett C; Rossi AG
J Immunol; 2002 Jun; 168(12):6232-43. PubMed ID: 12055237
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma.
Fujita M; Tohji C; Honda Y; Yamamoto Y; Nakamura T; Yagami T; Yamamori M; Okamura N
Int J Med Sci; 2012; 9(7):555-66. PubMed ID: 22991494
[TBL] [Abstract][Full Text] [Related]
15. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
18. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
Emi M; Maeyama K
Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
[TBL] [Abstract][Full Text] [Related]
19. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
20. The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells.
Okano H; Shiraki K; Inoue H; Kawakita T; Deguchi M; Sugimoto K; Sakai T; Murata K; Nakano T; Enjoji M
Int J Mol Med; 2003 Dec; 12(6):867-70. PubMed ID: 14612959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
